Second generation amplicor-HCV monitor assay: Clinical features and predictors of the response to interferon

Hepatology Research

Volumn 18, Issue 3, 2000, Pages 230-238

  Ide, Tatsuya ^a   Kumashiro, Ryukichi ^a   Toyoda, Naoko ^a   Matsuyama, Kazuhiro ^b   Miura, Toshiaki ^b   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Roch Diagnostics Japan   (Japan)

Author keywords

Amplicor HCV monitor assay (version 2.0); Chronic hepatitis C; Interferon treatment

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ACCURACY; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEVICE; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITOR; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

EID: 0033820132     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00069-3     Document Type: Article

References (25)

1. Treatment of chronic type C hepatitis with alpha interferon
2. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
3. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis
4. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France
5. Quantitative assay for hepatitis C virus in serum as predictors of the long-term response to interferon
6. Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon alpha
7. Comparison of 3 quantitative HCV RNA assays - Accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C
8. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection
9. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C
10. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: Relationship to genotypes of hepatitis C virus
11. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis
12. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy
13. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
14. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection
15. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology
16. Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C
17. Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA)
18. The HCV-bDNA probe method for measurement of HCV-RNA counts by HCV genotype
19. Molecular diagnostics by automated systems
20. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA
21. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources
22. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
23. A method of comparing the under receiver operating characteristic curves derived from the same cases
24. Analysis of freezer storage of serum from chronic HCV patients for use in HCV RNA testing: Results of 16 year retrospective analysis
25. Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs